[HTML][HTML] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - Frontiers in oncology, 2013 - frontiersin.org
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

[PDF][PDF] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - core.ac.uk
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms

PM Jones, R Drapkin - Frontiers in Oncology, 2013 - dash.harvard.edu
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms

PM Jones, R Drapkin - Frontiers in oncology, 2013 - pubmed.ncbi.nlm.nih.gov
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

[PDF][PDF] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - scienceopen.com
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

[PDF][PDF] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - 2013 - Citeseer
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

[PDF][PDF] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - med.upenn.edu
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

[PDF][PDF] Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - researchgate.net
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …

Modeling high-grade serous carcinoma: how converging insights into pathogenesis and genetics are driving better experimental platforms

PM Jones, R Drapkin - Advances in Epithelial Ovarian Cancer …, 2016 - books.google.com
In 2013, the American Cancer Society estimates that 22,240 women will receive a new
diagnosis of ovarian cancer and that 14,030 women will die from this disease, making …

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.

PM Jones, R Drapkin - Frontiers in Oncology, 2013 - europepmc.org
Recent developments in the study of epithelial ovarian cancer have called into question the
traditional views regarding the site of tumor initiation. Histopathologic studies and genomic …